Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.0493 +0.0393 (+3.89%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.0493 unch (unch) 15:48 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.0200
Day High
1.0500
Open 1.0350
Previous Close 1.0100 1.0100
Volume 13,400 13,400
Avg Vol 21,855 21,855
Stochastic %K 11.77% 11.77%
Weighted Alpha -86.41 -86.41
5-Day Change -0.1407 (-11.82%) -0.1407 (-11.82%)
52-Week Range 0.9900 - 8.9960 0.9900 - 8.9960
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,630
  • Shares Outstanding, K 5,365
  • Annual Sales, $ 8,510 K
  • Annual Income, $ -16,490 K
  • EBIT $ -22 M
  • EBITDA $ -19 M
  • 60-Month Beta 1.37
  • Price/Sales 0.64
  • Price/Cash Flow N/A
  • Price/Book 0.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +587,747.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9900 +5.99%
on 04/09/25
Period Open: 1.4050
1.4900 -29.58%
on 03/18/25
-0.3557 (-25.32%)
since 03/11/25
3-Month
0.9900 +5.99%
on 04/09/25
Period Open: 1.5700
1.8400 -42.97%
on 01/21/25
-0.5207 (-33.17%)
since 01/10/25
52-Week
0.9900 +5.99%
on 04/09/25
Period Open: 7.4350
8.9960 -88.34%
on 05/23/24
-6.3857 (-85.89%)
since 04/11/24

Most Recent Stories

More News
Evogene: Q4 Earnings Snapshot

Evogene: Q4 Earnings Snapshot

EVGN : 1.0493 (+3.89%)
Evogene: Q3 Earnings Snapshot

Evogene: Q3 Earnings Snapshot

EVGN : 1.0493 (+3.89%)
Evogene Provides Operational Update Amidst Current Security Situation in Israel

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...

EVGN : 1.0493 (+3.89%)
Casterra Delivers First Shipment of Castor Seeds to Africa

/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN)...

EVGN : 1.0493 (+3.89%)
Evogene Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery...

EVGN : 1.0493 (+3.89%)
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery

/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...

EVGN : 1.0493 (+3.89%)
Evogene Announces Pricing of US$8,500,000 Registered Direct Offering

/PRNewswire/ -- Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based...

EVGN : 1.0493 (+3.89%)
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience

/PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and a leading ag-biologicals company that develops microbiome-based,...

EVGN : 1.0493 (+3.89%)
CTVA : 59.28 (+2.31%)
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories

/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ("Evogene") (NASDAQ: EVGN)...

EVGN : 1.0493 (+3.89%)
Lavie Bio Receives Canadian Regulatory Approval for Thrivusâ„¢, Expanding Global Reach

/PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a leading ag-biological company focusing on improving food...

EVGN : 1.0493 (+3.89%)

Business Summary

Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene...

See More

Key Turning Points

3rd Resistance Point 1.0895
2nd Resistance Point 1.0698
1st Resistance Point 1.0595
Last Price 1.0493
1st Support Level 1.0295
2nd Support Level 1.0098
3rd Support Level 0.9995

See More

52-Week High 8.9960
Fibonacci 61.8% 5.9377
Fibonacci 50% 4.9930
Fibonacci 38.2% 4.0483
Last Price 1.0493
52-Week Low 0.9900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar